(Q78224657)
Statements
Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18) (English)
Yan J
Vetvicka V
Xia Y
Coxon A
Carroll MC
Mayadas TN
1 September 1999